Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis.

Wen YH, Koeppen H, Garcia R, Chiriboga L, Tarlow BD, Peters BA, Eigenbrot C, Yee H, Steiner G, Greco MA.

Hum Pathol. 2007 Aug;38(8):1184-91.

PMID:
17509661
2.

The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma.

Do SI, Jung WW, Kim HS, Park YK.

Int J Oncol. 2009 Mar;34(3):797-803.

PMID:
19212684
3.

Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.

Baumhoer D, Smida J, Specht K, Bink K, Quintanilla-Martinez L, Rosemann M, Siggelkow H, Nathrath WB, Atkinson MJ, Bielack S, Jundt G, Nathrath M.

Hum Pathol. 2011 Jun;42(6):859-66. doi: 10.1016/j.humpath.2010.09.016.

PMID:
21292304
4.

Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.

Park HR, Min K, Kim HS, Jung WW, Park YK.

Pathol Res Pract. 2008;204(8):575-82. doi: 10.1016/j.prp.2008.01.015.

PMID:
18440723
5.

Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma.

Hughes DP, Thomas DG, Giordano TJ, Baker LH, McDonagh KT.

Cancer Res. 2004 Mar 15;64(6):2047-53. Erratum in: Cancer Res. 2013 Jul 1;73(13):4169.

6.

Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma.

Ganti R, Skapek SX, Zhang J, Fuller CE, Wu J, Billups CA, Breitfeld PP, Dalton JD, Meyer WH, Khoury JD.

Mod Pathol. 2006 Sep;19(9):1213-20.

7.

Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.

Kersting C, Gebert C, Agelopoulos K, Schmidt H, van Diest PJ, Juergens H, Winkelmann W, Kevric M, Gosheger G, Brandt B, Bielack S, Buerger H.

Clin Cancer Res. 2007 May 15;13(10):2998-3005.

8.

Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.

Dobashi Y, Suzuki S, Sugawara H, Ooi A.

Hum Pathol. 2007 Jun;38(6):914-25.

PMID:
17376509
11.

Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.

Cai CQ, Peng Y, Buckley MT, Wei J, Chen F, Liebes L, Gerald WL, Pincus MR, Osman I, Lee P.

Oncogene. 2008 May 15;27(22):3201-10. doi: 10.1038/sj.onc.1210983.

PMID:
18193092
12.
13.

Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.

Entz-Werlé N, Marcellin L, Gaub MP, Guerin E, Schneider A, Berard-Marec P, Kalifa C, Brugiere L, Pacquement H, Schmitt C, Tabone MD, Jeanne-Pasquier C, Terrier P, Dijoud F, Oudet P, Lutz P, Babin-Boilletot A.

J Clin Oncol. 2005 Apr 1;23(10):2248-55.

PMID:
15800315
14.

Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome.

Sulzbacher I, Birner P, Dominkus M, Pichlhofer B, Mazal PR.

Pathology. 2010 Dec;42(7):664-8. doi: 10.3109/00313025.2010.520310.

PMID:
21080877
15.

A complex pattern of chemokine receptor expression is seen in osteosarcoma.

von Luettichau I, Segerer S, Wechselberger A, Notohamiprodjo M, Nathrath M, Kremer M, Henger A, Djafarzadeh R, Burdach S, Huss R, Nelson PJ.

BMC Cancer. 2008 Jan 24;8:23. doi: 10.1186/1471-2407-8-23.

16.

Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.

Fieten H, Spee B, Ijzer J, Kik MJ, Penning LC, Kirpensteijn J.

Vet Pathol. 2009 Sep;46(5):869-77. doi: 10.1354/vp.08-VP-0155-F-FL.

PMID:
19429984
17.

Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis.

Selvarajah GT, Verheije MH, Kik M, Slob A, Rottier PJ, Mol JA, Kirpensteijn J.

Vet J. 2012 Aug;193(2):412-9. doi: 10.1016/j.tvjl.2012.02.009.

PMID:
22436430
18.

Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma.

Sulzbacher I, Birner P, Trieb K, Träxler M, Lang S, Chott A.

Mod Pathol. 2003 Jan;16(1):66-71.

19.
20.

Evaluation of Her-2/neu gene status in osteosarcoma by fluorescence in situ hybridization and multiplex and monoplex polymerase chain reactions.

Willmore-Payne C, Holden JA, Zhou H, Gupta D, Hirschowitz S, Wittwer CT, Layfield LJ.

Arch Pathol Lab Med. 2006 May;130(5):691-8.

PMID:
16683887
Items per page

Supplemental Content

Support Center